Humana (HUM) Competitors

Elevance Health (NYSE:ELV) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends, community ranking and analyst recommendations.

Does the media prefer ELV or HUM?

In the previous week, Humana had 12 more articles in the media than Elevance Health. MarketBeat recorded 27 mentions for Humana and 15 mentions for Elevance Health. Humana's average media sentiment score of 0.65 beat Elevance Health's score of 0.49 indicating that Humana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	5 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Humana	9 Very Positive mention(s)	5 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer ELV or HUM?

Humana received 30 more outperform votes than Elevance Health when rated by MarketBeat users. However, 67.21% of users gave Elevance Health an outperform vote while only 63.02% of users gave Humana an outperform vote.

Company	Underperform	Outperform
Elevance Health	Outperform Votes 863 67.21%	Underperform Votes 421 32.79%
Humana	Outperform Votes 893 63.02%	Underperform Votes 524 36.98%

Is ELV or HUM a better dividend stock?

Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.8%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.4%. Elevance Health pays out 23.8% of its earnings in the form of a dividend. Humana pays out 31.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 13 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Is ELV or HUM more profitable?

Elevance Health has a net margin of 3.68% compared to Humana's net margin of 1.18%. Elevance Health's return on equity of 19.56% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	3.68%	19.56%	7.22%
Humana	1.18%	13.20%	4.47%

Do analysts prefer ELV or HUM?

Elevance Health presently has a consensus target price of $539.20, indicating a potential upside of 47.34%. Humana has a consensus target price of $300.50, indicating a potential upside of 21.61%. Given Elevance Health's stronger consensus rating and higher possible upside, research analysts plainly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.81
Humana	0 Sell rating(s)	19 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.24

Do institutionals & insiders believe in ELV or HUM?

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.4% of Elevance Health shares are owned by company insiders. Comparatively, 0.3% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has better valuation and earnings, ELV or HUM?

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$174.02B	0.49	$5.99B	$27.43	13.34
Humana	$115.01B	0.26	$2.49B	$11.29	21.89

Which has more risk and volatility, ELV or HUM?

Elevance Health has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.53, meaning that its stock price is 47% less volatile than the S&P 500.

Summary

Elevance Health beats Humana on 17 of the 22 factors compared between the two stocks.